Skip to main content

Tosymra

Generic name: sumatriptan
Dosage form: nasal spray
Drug class: Antimigraine agents

Medically reviewed by Melisa Puckey, BPharm. Last updated on Aug 23, 2023.

What is Tosymra?

Tosymra is a nasal spray medicine used to treat acute migraine headaches with or without aura in adults.
It is not used to treat other types of headaches such as hemiplegic (that make you unable to move on one side of your body) or basilar (rare form of migraine with aura) migraines.

Tosymra is not used to prevent or decrease the number of migraines you have. Tosymra is not used to treat cluster headaches. It is not known if it is safe and effective in children under 18 years of age.

Tosymra is a serotonin (5-HT1B/1D) receptor agonist (triptan)

Important information

Tosymra can cause serious side effects, including:

Heart attack and other heart problems. Heart problems may lead to death.

Stop taking Tosymra and get emergency medical help right away if you have any of the following symptoms of a heart attack:

Tosymra is not for people with risk factors for heart disease unless a heart exam is done and shows no problem. You have a higher risk for heart disease if you:

Who should not use Tosymra?

Do not take Tosymra if you have:

Ask your healthcare provider if you are not sure if your medicine is listed above.

Before using Tosymra

Before taking Tosymra, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use Tosymra?

What should I avoid while using Tosymra?

Tosymra can cause dizziness, weakness, or drowsiness. If you have these symptoms, do not drive a car, use machinery, or do anything where you need to be alert.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Dosing information

The recommended dose of Tosymra is 10 mg given as a single spray in one nostril.

The maximum cumulative dose that may be given in a 24-hour period is 30 mg, with doses of Tosymra separated by at least 1 hour. Tosymra may also be given at least 1 hour following a dose of another sumatriptan product.

What are the side effects of Tosymra?

Tosymra may cause serious side effects.

Also see “Important information"

These serious side effects include:

The most common side effects of Tosymra include:

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Tosymra. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1- 800-FDA-1088.

Interactions

Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure. Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.

Pregnancy and breastfeeding

Pregnancy or planning to become pregnant: Tell your doctor. It is not known if Tosymra can harm your unborn baby.

Breastfeeding or planning to breastfeed. Tosymra passes into your breast milk. It is not known if this can harm your baby. Talk with your healthcare provider about the best way to feed your baby if you take Tosymra.

Storage

Store between 20°C and 25°C (68°F and 77°F).

Excursions permitted between 15°C and 30°C (59°F and 86°F).

Do not store in the refrigerator or freezer.

What are the ingredients in Toymra?

Active ingredient: Sumatriptan

Inactive ingredients: citric acid monohydrate, n-Dodecyl beta-D-maltoside, potassium phosphate monobasic, sodium chloride, and sodium phosphate dibasic anhydrous in water for injection.

References

Popular FAQ

Imitex (sumatriptan) can start to work within 30 minutes of taking a dose. However, it may take a few hours for you to notice the full effects. Continue reading

Ubrelvy and Imitrex are both oral tablets used to treat migraine, but there are differences in the way they work. Ubrelvy prevents a protein called CGRP thought to play a role in migraine attacks from binding to its receptor and Imitrex is thought to bind to serotonin 5‑HT1B/1D receptors, and inhibit pro-inflammatory substances Although no head-to-head comparison trials compare Ubrelvy to Imitrex, indirect evidence suggests that overall, Ubrelvy is no more effective, and may be inferior to Imitrex at relieving migraine in adults who are able to tolerate triptans. For those adults with moderate-to-severe migraine attacks that cannot tolerate triptans or who have found them ineffective, Ubrelvy is beneficial for treating migraines compared to no treatment. Ubrelvy is associated with fewer side effects than Imitrex, but is more expensive, costing almost twice as much. Continue reading

More FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.